Related Experiment Video

Updated: Nov 1, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.7K

COVID-19 vaccine development from the perspective of cancer patients

Yang He1, Yi Ding2, Bo Cao1

  • 1Department of Gynecological Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Human Vaccines & Immunotherapeutics
|June 25, 2021
PubMed

Insights

COVID-19 vaccines offer benefits to cancer patients, but safety and efficacy data in this population are lacking. Clinical trials are urgently needed to assess COVID-19 vaccine use in individuals with cancer.

Area of Science:

  • Oncology
  • Immunology
  • Public Health

Background:

  • The COVID-19 pandemic poses significant risks to cancer patients, a vulnerable population.
  • While numerous COVID-19 vaccines are available, data on their use in cancer patients is limited.
  • Understanding vaccine impact on cancer patients is crucial for public health strategies.

Purpose of the Study:

  • To review the current status and challenges of COVID-19 vaccination in cancer patients.
  • To highlight the urgent need for clinical trials evaluating vaccine safety and efficacy in this demographic.
  • To assess cancer patient and family member acceptance of COVID-19 vaccines.

Main Methods:

  • Literature review on COVID-19 vaccine use in cancer patients.
  • Discussion of potential issues and benefits.
  • Presentation of original survey data on vaccine acceptance among 209 cancer patients and family members.

Main Results:

  • Cancer patients may experience social and medical benefits from COVID-19 vaccination.
  • There is a notable lack of specific clinical trial data for COVID-19 vaccines in cancer patients.
  • Survey indicates a need for further investigation into vaccine acceptance and concerns.

Conclusions:

  • COVID-19 vaccines hold potential benefits for cancer patients.
  • There is a critical need for robust clinical trials to establish safety and effectiveness in cancer patients.
  • Further research is essential to inform vaccination policies for immunocompromised individuals.
Keywords:
COVID-19COVID-19 vaccineCancer patientsSARS-CoV-2clinical trialsimmunosuppression

More Related Videos

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction10:18

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

1.5K
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

935

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
590
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.9K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
51.3K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
790
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.6K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K